OrbiMed’s Corvus Pharmaceuticals CRVS Stock Holding History

OrbiMed’s Portfolio CRVS Stock Details CRVS Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$28.7M	Buy	7,165,006 +221,352	+3%	+$885K	0.72%	36
2025 Q1	$22.1M	Hold	6,943,654	–	–	0.53%	41
2024 Q4	$37.1M	Hold	6,943,654	–	–	0.76%	39
2024 Q3	$36.7M	Hold	6,943,654	–	–	0.67%	43
2024 Q2	$12.6M	Hold	6,943,654	–	–	0.25%	67
2024 Q1	$12.4M	Hold	6,943,654	–	–	0.23%	76
2023 Q4	$12.2M	Hold	6,943,654	–	–	0.24%	72
2023 Q3	$10.1M	Hold	6,943,654	–	–	0.22%	83
2023 Q2	$15.9M	Hold	6,943,654	–	–	0.29%	75
2023 Q1	$6.32M	Hold	6,943,654	–	–	0.12%	95
2022 Q4	$5.9M	Hold	6,943,654	–	–	0.11%	90
2022 Q3	$5.68K	Hold	6,943,654	–	–	0.11%	102
2022 Q2	$6.88K	Hold	6,943,654	–	–	0.12%	103
2022 Q1	$11.4M	Hold	6,943,654	–	–	0.18%	94
2021 Q4	$16.7M	Hold	6,943,654	–	–	0.22%	95
2021 Q3	$33.6M	Sell	6,943,654 -1,109,644	-14%	-$5.37M	0.37%	71
2021 Q2	$21.5M	Hold	8,053,298	–	–	0.22%	95
2021 Q1	$24.8M	Buy	8,053,298 +1,285,714	+19%	+$3.96M	0.23%	89
2020 Q4	$24.1M	Hold	6,767,584	–	–	0.21%	92
2020 Q3	$27.1M	Hold	6,767,584	–	–	0.34%	75
2020 Q2	$18.4M	Hold	6,767,584	–	–	0.26%	80
2020 Q1	$14.3M	Hold	6,767,584	–	–	0.24%	77
2019 Q4	$36.8M	Hold	6,767,584	–	–	0.53%	53
2019 Q3	$20.4M	Buy	6,767,584 +201,899	+3%	+$608K	0.39%	64
2019 Q2	$24.6M	Buy	6,565,685 +598,101	+10%	+$2.24M	0.38%	60
2019 Q1	$24M	Hold	5,967,584	–	–	0.37%	65
2018 Q4	$21.9M	Hold	5,967,584	–	–	0.41%	65
2018 Q3	$51.2M	Hold	5,967,584	–	–	0.62%	49
2018 Q2	$65.5M	Hold	5,967,584	–	–	0.78%	40
2018 Q1	$68.8M	Buy	5,967,584 +588,235	+11%	+$6.78M	0.85%	40
2017 Q4	$55.7M	Hold	5,379,349	–	–	0.7%	43
2017 Q3	$85.7M	Hold	5,379,349	–	–	0.82%	37
2017 Q2	$65.1M	Hold	5,379,349	–	–	0.68%	47
2017 Q1	$112M	Hold	5,379,349	–	–	1.27%	27
2016 Q4	$76.9M	Hold	5,379,349	–	–	0.98%	33
2016 Q3	$88.5M	Hold	5,379,349	–	–	1.01%	37
2016 Q2	$76.7M	Buy	5,379,349 +120,899	+2%	+$1.72M	0.8%	43
2016 Q1	$76.2M	Buy	+5,258,450	New	+$76.2M	0.8%	39